Загрузка...
Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma
Immune checkpoint inhibition has resulted in dramatic improvements in overall and relapse-free survival in patients with metastatic melanoma. The most commonly used immune checkpoint inhibitors are monoclonal antibodies targeting programmed cell death protein 1 and cytotoxic T-lymphocyte-associated...
Сохранить в:
| Опубликовано в: : | Front Med (Lausanne) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425878/ https://ncbi.nlm.nih.gov/pubmed/30931305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00027 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|